Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1985-12-11
1988-09-20
Rollins, John
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424154, 514891, A61K 3300, A61K 3306
Patent
active
047724676
ABSTRACT:
A process for dietary calcium supplementation. Oral dosage of a composition comprising calcium citrate is utilized to provide an efficiently absorbable chemical form of calcium, while raising urinary level of citrate. Because of improved absorption of calcium, osteoporosis development is precluded. Since citrate retards precipitation of stone-forming calcium stones, the risk of calcium nephrolithiasis (resulting from calcium supplementation) is reduced.
REFERENCES:
patent: 3105792 (1963-10-01), White
patent: 3653914 (1972-04-01), Schmidt
patent: 4107346 (1978-08-01), Kravitz
patent: 4185093 (1980-01-01), Carnes et al.
patent: 4214996 (1980-07-01), Buddemmeyer et al.
patent: 4289750 (1981-09-01), Kopp et al.
patent: 4405596 (1983-09-01), Helbig et al.
patent: 4551342 (1985-11-01), Natel et al.
patent: 4614648 (1986-09-01), Bru
Rubin Newspaper Clipping, (Austin American Statesman, 11/15/85).
Harvey et al., (J. Clin. Endocrin. Met., 61:1233, (1985)).
Nicar and Pack, (J. Clin. Endocrin. Met., 61:391, (1985).
Bo-Linn et al., (J. Clin. Invest., 73:640, (1984)).
Packett, et al., (1968), J. Animal Science, 27:1716-1721.
Butz and Dulce, Urolithiasis Clinical and Basic Research, (1980), Robertson et al. eds., Plenum Press, London, pp. 881-884.
Baruch et al., Med. Clin. N. Amer., (1975), 59:569-582.
Packett et al., (date not available), "Mineral Studies in Ovine Phosphatic Urolithiasis", pp. 1716-1720.
WO85/05552 International Publication, Dec. 19, 1985.
PCT International Search Report.
Hunt and Johnson, (Digestive Dis. and Sci., 28:417, (1983)).
Leskovar et al., (Urol. Int., 36:325, (1981)).
Rudman et al., (N. Eng. J. Med., 303:657, (1980)).
Federal Register, (Mar. 16, 1979).
Unlisted Drugs, (1976), Reference C.
News Release from Proctor and Gamble.
Peacock et al., (Brit. Med. J., Jun., p. 729, (1968)).
Clarkson et al., (Clin. Sci., 30:425, (1966)).
McDonald et al., (Clin. Sci., 26:27, (1964)).
Niepmann, (Klin. Wochschr., 39:1064-1071, (1961)).
Rote Liste, (1961).
Jungmann et al., (Medizinische Klinik, (1934)).
Bonick, (1986), (Letter to Newsweek, 2/17/86).
Kolata, (Science, 233:519, (1986)).
Bishop article from the Wall Street Journal, (1986).
Abstract by Christiansen et al., (J. Bone Min. Res., 1, (1986)).
Abstract by Matkovit et al., (J. Bone Min. Res., 1, (1986)).
Abstract by Rigges et al., (J. Bone Min. Res., 1, (1986)).
Kotulak article, (Austin American Statesman, 3/30/86).
Brody, (N.Y. Times, 12/17/85).
Pekkanen, (Reader's Digest, 11/85).
Edelstein Article in Ladies Home Journal, (1985).
Sakhaee et al., (J. Clin. Endocrin. Met., 61:368, (1985)).
Consensus Development Conference Statement from the National Institute of Health, (1984).
Skilman, (Consultant, 2/84).
Kurtz et al., (Science, 222:1139, (1984)).
Ackley et al., (Am. J. Clin. Nutr., 38:457, (1983)).
Belizan, (J. Am. Med. Ass'n, 249:1161, (1983), #1)).
Belizan et al., (Am. J. Obstet. Gynecol., 146:175, (1983, #2)).
Nordenvall et al., (Eur. Urol., 9:35, (1983)).
McCarron et al., (Science, 217:267, (1982)).
McCarron, (1982), (N. Eng. J. of Med., 307:226).
Riggs et al., (New Eng. J. Med., 306:446, (1982)).
Strauss et al., (Am. J. Med., 72:17, (1982)).
Butz and Rost, (5th Symp. on Exptl. Urol., p. 243, (1980)).
Hartung et al., (5th Symp. on Exptl. Urol., p. 243, (1980)).
Nordin et al., (Brit. Med. J., p. 451, (1980)).
Barilla et al., (Am. J. Med., 64:579, (1978)).
Federal Register, (3/16/79).
Heaney et al., (J. Lab. Clin. Med., 92:953, (1978)).
Pak, (Calcium Nephrolithiasis, Plenum, N.Y., p. 5, (1978)).
Recker et al., (Ann. Int. Med., 87:649, (1977)).
Pak, (Urolithiasis Res., Plenum, N.Y. p. 213, (1976)).
Pak et al., (J. Clin. Invest., 54:387, (1974, #1)).
Pak et al., (N. Eng. J. Med., 290:175, (1974, #2)).
Chapter by Forbes and Demsey.
Pogainis and Shaw, (1957), (Proc. S. D. Acad. Sci., XXXVI, p. 56).
Chatterjee and Dhar (J. Physical Chemistry, 28
Research leading to development of the present invention was supported in part by grants P01-AM20543 and R01-AM-6061 from the National Institutes of Health, Department of Health and Human Services, United States of America.
Board of Regents, U T Systems
Rollins John
LandOfFree
Osteoporosis inhibition by dietary calcium supplementation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteoporosis inhibition by dietary calcium supplementation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteoporosis inhibition by dietary calcium supplementation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1747642